- Home
- YELP vs ZLAB Comparison
YELP vs ZLAB Comparison
Compare YELP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YELP | ZLAB |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2012 | 2017 |
Fundamental Metrics
Financial Performance| Metric | YELP | ZLAB |
|---|---|---|
| Price | $31.16 | $17.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $32.00 | ★ $57.22 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.30 | N/A |
| EPS | ★ 2.25 | N/A |
| Revenue | ★ $1,466,918,000.00 | $441,629,000.00 |
| Revenue This Year | $5.87 | $30.20 |
| Revenue Next Year | $2.94 | $34.71 |
| P/E Ratio | $13.93 | ★ N/A |
| Revenue Growth | 5.34 | ★ 24.14 |
| 52 Week Low | $27.29 | $16.82 |
| 52 Week High | $41.72 | $44.34 |
Technical Indicators
Market Signals| Indicator | YELP | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 31.02 |
| Support Level | $30.04 | $16.82 |
| Resistance Level | $30.94 | $18.67 |
| Average True Range (ATR) | 0.67 | 0.60 |
| MACD | 0.26 | 0.13 |
| Stochastic Oscillator | 93.63 | 33.24 |
Price Performance
Historical ComparisonAbout YELP Yelp Inc.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.